Vaccine capable of inducing formation of antibodies directed to proprotein convertase subtilisin/kexin type 9 (PCSK9) in vivo

US9533030B2 · kind B2 · utility

Assignee

• AFFIRIS AG · AT

Inventors

• Sylvia Brunner · Wien, AT
• Gergana Galabova · Wien, AT
• Gabriele Winsauer · Wien, AT
• Erika Bilcikova · Bratislava, SK
• Claudia Juno · Wien, AT
• Pola Linzmayer-Hirt · Wiener Neudorf, AT
• Birgit Schuh · Wien, AT
• Guenther Staffler · Wien, AT

Key dates

• Filing date: Aug 28, 2013
• Grant date: Jan 3, 2017
• Expiry date: Aug 28, 2033

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K2039/6081
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to a vaccine capable to induce the formation of antibodies directed to PCSK9 in vivo.